Blog

Uber Technologies (UBER) is quickly becoming one of the most compelling stories in the market, and I say that as someone who once believed the company was destined to fail. But Uber has done

MPLX LP MPLX reported first-quarter 2025 earnings of $1.10 per unit, which topped the Zacks Consensus Estimate of $1.06. The bottom line also improved from the year-ago quarter’s level of 98 cents.

Cytokinetics, Incorporated CYTK reported a net loss of $1.36 per share for the first quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of $1.41. In the year-ago quarter, the

Solventum SOLV is scheduled to release first-quarter 2025 results on May 8, after market close. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 7.63%. SOLV

Denali Therapeutics DNLI reported a first-quarter 2025 loss of 78 cents per share, wider than the Zacks Consensus Estimate of a loss of 71 cents. The company reported a loss of 68 cents in the

Cencora, Inc. COR reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of $4.42, which beat the Zacks Consensus Estimate of $4.08 by 8.3%. The bottom line also improved 16.3% year

UBS Group AG UBS has entered a strategic partnership with General Atlantic, a US-based investment firm, to focus on private credit opportunities.

Details of the Partnership Between UBS and General

Avanos Medical, Inc. AVNS reported first-quarter 2025 adjusted earnings per share (EPS) from continuing operations of 26 cents, up 18.2% year over year. The bottom line surpassed the Zacks Consensus

Bunge Global SA BG reported first-quarter 2025 adjusted earnings of $1.81 per share, which beat the Zacks Consensus Estimate of $1.27 by a margin of 42.5%. The bottom line, however, marked a 40.5%

Intel Corporation INTC recently announced that it has successfully achieved industry-first full NPU (Neural Processing Unit) compliance in the MLPerf Client v0.6 benchmark. MLPerf is an

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Gildan Activewear Inc. GIL has shown an outstanding 44.8% surge in its stock price over the past year. The stock has outperformed the broader Consumer Discretionary sector and the S&P 500, which

Waters Corporation WAT reported first-quarter 2025 non-GAAP earnings of $2.25 per share, beating the Zacks Consensus Estimate by 1.35% and increasing 1.8% year over year. Net sales of $662 million

Terex Corporation TEX reported adjusted earnings per share of 83 cents, which beat the Zacks Consensus Estimate of 49 cents. The bottom line, however, plunged 52% from the prior-year quarter’s

Shares of AMERISAFE, Inc. AMSF lost 5.5% since it reported first-quarter 2025 results on April 29. The quarterly results were hurt by a drop in net investment income and softer underwriting results

Ralph Lauren Corporation RL has retained its solid market foothold by focusing on brand elevation, a diversified growth strategy and its Next Great Chapter: Accelerate plan. RL stock has been

Trimble TRMB has reported first-quarter 2025 non-GAAP earnings of 61 cents per share, surpassing the Zacks Consensus Estimate by 3.39%. The metric decreased 4.7% year over year.Revenues of $840.6

Fresenius Medical Care AG & Co. FMS reported first-quarter 2025 adjusted earnings per share (EPS) of 44 cents, which surpassed the Zacks Consensus Estimate by 2.1%. The bottom line improved 22.2%

Clover Health Investments, Corp. CLOV reported breakeven earnings for the first-quarter 2025, narrower than the year-ago period’s loss of 5 cents. The bottom line surpassed the Zacks Consensus

Masimo Corporation MASI delivered adjusted earnings per share (EPS) of $1.36 in the first quarter of 2025, up 56.3% year over year. The figure beat the Zacks Consensus Estimate by 9.7%. (Find the